Walgreen (WAG) July Comps Rise 2%
Tweet
Share
E-mail
Walgreens (NYSE: WAG) reported that July sales rose 7.3% and sales in comparable stores (those open at least a year) increased 2%.
Comparable store front-end sales decreased 1.3 percent. Front-end sales were hurt by slowing sales of discretionary items in a challenging economy.
July pharmacy sales increased 8.4 percent, while comparable pharmacy sales increased 3.8 percent. Comparable pharmacy sales were negatively impacted by 4.0 percentage points due to generic drug introductions in the last 12 months.
Prescriptions filled at comparable stores increased 5.0 percent in July, including 1.7 percentage points due to more patients filling 90-day prescriptions. Pharmacy sales accounted for 66.8 percent of total sales for the month.
Comparable store front-end sales decreased 1.3 percent. Front-end sales were hurt by slowing sales of discretionary items in a challenging economy.
July pharmacy sales increased 8.4 percent, while comparable pharmacy sales increased 3.8 percent. Comparable pharmacy sales were negatively impacted by 4.0 percentage points due to generic drug introductions in the last 12 months.
Prescriptions filled at comparable stores increased 5.0 percent in July, including 1.7 percentage points due to more patients filling 90-day prescriptions. Pharmacy sales accounted for 66.8 percent of total sales for the month.
You May Also Be Interested In
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
